Effect of a phosphate supplement on urine pH in patients with neurogenic bladder receiving intermittent catheterization.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 15570319.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pilot study; prospective design. University Hospital, Virginia, USA. To examine a phosphorus supplement as a urine-acidifying agent in patients with neurogenic bladder on clean intermittent catheterization. Seven patients were followed for 4 weeks. For the first week of study urine pH was measured three times a day: first morning urine sample, afternoon sample, evening sample. For the second and third weeks urine pH was measured and the patients drank a phosphorus supplement three times a day. For the fourth week of study the patients did not take the phosphorus supplement but the measurement of urine pH was continued. The patients were visited in their homes twice a week. During each visit a sample of urine was collected for culture. A supplement container count was performed and urine pH recordings were checked. There was no significant change in urine pH during the 2-week period when a patient was on phosphorus supplementation compared to when the patient was off supplementation. In addition, urine acidification was not achieved over the time period when urine pH was monitored. Phosphate supplementation had no effect on urine pH in patients with neurogenic bladder.
Medical subject headings
- Bacteriuria
- Dietary Supplements
- Phosphates
- Urinary Bladder, Neurogenic
- Urine